Metabolic Risk Management, Physical Exercise and Lifestyle Counselling in Low-active Adults; Controlled Randomized Trial (BELLUGAT)

August 19, 2019 updated by: Assumpta Ensenyat, INEFC-Lleida

Supervised Physical Exercise and Lifestyle Counselling in the Management of Metabolic Risk in Low-active Adults; a Controlled Randomized Trial. Belluga't de CAP a Peus

The purpose of this study is evaluate the effectiveness of different doses of supervised exercise training intensity -concomitant to lifestyle counselling- as a Primary Health Care intervention tool for the management of the metabolic syndrome in low active adults with one or more metabolic risk factors.

Secondary aims of the study are to investigate the effects of these interventions on systemic inflammation and adipose tissue function, cardiorespiratory fitness, physical activity and sedentary habits, and the cost-effectiveness of the intervention with regard to health related quality of life.

The general hypothesis is that adults with risk factors for metabolic syndrome participating in interventions for the promotion of a healthy lifestyle that together with counselling strategies will include supervised physical exercise of vigorous intensity will present greater improvements in terms of metabolic risk, physical condition, physical activity/sedentary behaviours and psychological parameters at the end of the intervention and at 6-months follow-up than participants in interventions for the promotion of a healthy lifestyle that will include counselling plus physical exercise of low-to-moderate intensity or interventions based exclusively on counselling.

It is a three arms controlled randomized clinical trial implemented in the Primary Health Care setting and of 10 months duration.

Study Overview

Detailed Description

The purpose of this study is evaluate the effectiveness of different doses of supervised exercise training intensity -concomitant to lifestyle counselling- as a Primary Health Care intervention tool for the management of the metabolic syndrome in low active adults with one or more metabolic risk factors.

Secondary aims of the study are to investigate the effects of these interventions on systemic inflammation and adipose tissue function, cardiorespiratory fitness, physical activity and sedentary habits, and the cost-effectiveness of the intervention with regard to health related quality of life.

The general hypothesis is that adults with risk factors for metabolic syndrome participating in interventions for the promotion of a healthy lifestyle that together with counselling strategies will include supervised physical exercise of vigorous intensity will present greater improvements in terms of metabolic risk, physical condition, physical activity/sedentary behaviours and psychological parameters at the end of the intervention and at 6-months follow-up than participants in interventions for the promotion of a healthy lifestyle that will include counselling plus physical exercise of low-to-moderate intensity or interventions based exclusively on counselling.

It is a three arms controlled randomized clinical trial implemented in the Primary Health Care setting and of 10 months duration.

Adults aged 30 to 52 years with metabolic risk factors will be randomized in three intervention groups that will be given one of the following: assessment on healthy lifestyle plus high intensity physical exercise supervision (3 individual and 6 group sessions + 16 supervised training lessons); assessment plus low-to-moderate intensity physical exercise supervision (3 individual and 6 group sessions + 16 supervised training lessons) or assessment-based programme without physical exercise supervision (3 individual and 6 group sessions).

The main output variables evaluated will be: a) risk factors for the metabolic syndrome (waist circumference, blood pressure, and plasma triglycerides, high density lipoproteins and glucose), systemic inflammation and adipose tissue functionality, physical activity habits and sedentary conducts, dietary habits, quality of life related to health, self-efficacy and empowerment. The economic cost will also be analysed to determine the cost-effectiveness of the program. These variables will be assessed 3 times alongside the study: at baseline, at the end of the 4 months intervention, and at 6 months follow-up. It has been estimated to recruit 33 participants per group, which are 100 participants.

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lleida, Spain, 25192
        • INEFC-Lleida

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 52 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Low active (achieving less than 150 minutes/week of moderate-to-vigorous physical activity or have not participated in any supervised exercise programs for at least the last 6 months).
  • Having one or more risk factors for metabolic syndrome (Marcuello et al., 2013) (waist circumference >94.5 cm for men and >89.5 cm for women; blood pressure ≥130/85 mmHg; triglycerides in plasma ≥150 mg/dL; high density lipoprotein cholesterol in plasma <40 mg/dL for men and <50 mg/dL for women; fasting glycaemia ≥100 mg/dL).
  • Accept and sign the written informed consent.
  • Accept the randomized group assignment.

Exclusion Criteria:

  • Couples or individuals living in the same house
  • Morbid obesity (BMI ≥ 40).
  • A past/current history and/or physical examination or laboratory findings of significant diseases of cardiovascular, respiratory, neuromuscular, psychiatric diseases/disorders.
  • Diseases/disorders that may contraindicate performing physical exercise or a stress test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Lifestyle counseling
This group will receive lifestyle counselling but not supervised exercise training sessions
The counselling program consists of 6 group meetings of 1 hour and 3 individual consultations of at least 15 minutes each. Sessions will be set up with the aim to enhance knowledge and empowerment related to physical activity, sedentary conducts, dietary habits, as well as strategies for behaviour change will be given. Individual consultations will focus on establishing realistic objectives and to involve the participants in taking decisions.
Experimental: Aerobic interval training
This group will receive lifestyle counselling plus supervised high intensity (80%VO2max) interval exercise training sessions
The counselling program consists of 6 group meetings of 1 hour and 3 individual consultations of at least 15 minutes each. Sessions will be set up with the aim to enhance knowledge and empowerment related to physical activity, sedentary conducts, dietary habits, as well as strategies for behaviour change will be given. Individual consultations will focus on establishing realistic objectives and to involve the participants in taking decisions.
The supervised aerobic interval training will consist of 16 supervised group training lessons lasting 60 minutes and 32 individual nonsupervised training lessons that would be self-administered by each participant. The main part of the training lessons will consist of 4 series of 4 minutes of cycling at a heart rate of 80% of the VO2peak interspersed with active pauses of 2 minutes at 60% of the VO2peak .
Active Comparator: Traditional continous training
This group will receive lifestyle counselling plus supervised moderate intensity (60%VO2max) continous exercise training sessions
The counselling program consists of 6 group meetings of 1 hour and 3 individual consultations of at least 15 minutes each. Sessions will be set up with the aim to enhance knowledge and empowerment related to physical activity, sedentary conducts, dietary habits, as well as strategies for behaviour change will be given. Individual consultations will focus on establishing realistic objectives and to involve the participants in taking decisions.
The supervised traditional continous training will consist of 16 supervised group training lessons lasting 60 minutes and 32 individual nonsupervised training lessons that would be self-administered by each participant. The main part of the training lessons will consist of activities such as walking, cycling, or tonification exercises always at an intensity of 60% of the VO2peak.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in metabolic risc score
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
A continuous metabolic syndrome risk score (cMSSy) will be calculated as described by Wijndaele (Wijndaele et al., 2006). The score contains the five risk factors considered in the definition of the metabolic syndrome (Expert panel on detection, 2001; Marcuello et al., 2013), that is waist circumference, triglycerides, high density lipoproteins cholesterol, systolic blood pressure and plasma glucose.
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in cardiorespiratory fitness
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Improvement of peak oxygen uptake (VO2peak). Cardiorespiratory fitness will be assessed by means of voluntary maximal graded exercise on a cycle ergometer while measuring oxygen consumption (VO2).
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in active lifestyle
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Daily time spent at moderate-to-vigorous physical activity. Participants will wear Actigraph accelerometers (GT3X+ models) during all day for seven consecutive days. Cut points for moderate-to-vigorous physical activity will be set above 2020 counts per minute.
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in sedentary time
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Reduction of the daily time devoted to sedentary conducts. Participants will wear Actigraph accelerometers (GT3X+ models) during all day for seven consecutive days. Cut points for sedentary conducts will be set under 100 counts per minute.
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in dietary habits
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Improvement of healthy eating index
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in physical activity self-efficacy questionnaire
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Spanish version of the physical activity scale (Fernández-Cabrera, Medina, Rueda, Ordoñez, & León, 2012)
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in empowerment
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Health Empowerment Scale (HES) (Serrani, 2014)
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in health related quality of life at the end of the intervention
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Quality of life questionaire (EQ-5D)
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in health related quality of life
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Quality of life questionaire (EQ-5D)
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in interleucin-6
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Fasting blood samples will be drawn to determine interleukin by cytometry.
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in adiponectin
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Fasting blood samples will be drawn to determine adiponectin by cytometry.
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Change from baseline in plasma metabolome
Time Frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.
Fasting blood samples will be drawn to determine plasma metabolome.
3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost-effectiveness of the intervention
Time Frame: 4 months
Direct and indirect costs of setting and running the interventions will be collected for the economic evaluation analysis by means of questionnaires. HRQoL scores will be used to weight survival years and generate quality adjusted life years (QALYs ). The cost-effectiveness analysis will be conducted according to the current practice methods for economic evaluation (Frew et al., 2014).
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Assumpta Ensenyat, MD, PhD, INEFC-Lleida

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

December 31, 2017

Study Registration Dates

First Submitted

July 6, 2016

First Submitted That Met QC Criteria

July 13, 2016

First Posted (Estimate)

July 14, 2016

Study Record Updates

Last Update Posted (Actual)

August 21, 2019

Last Update Submitted That Met QC Criteria

August 19, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

At present we have not planned to share data. Probably at the end of the trail we will put them on the repository of the University of Lleida.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Risk Factor

Clinical Trials on Lifestyle

3
Subscribe